Kinney Jefferson (22 results)

Paperback. Condition: Fine.

hardcover. Condition: Very Good. Open Books is a nonprofit social venture that provides literacy experiences for thousands of readers each year through inspiring programs and creative capitalization of books.

hardcover. Condition: Good. Cover and edges may have some wear.

hardcover. Condition: Very Good. Cover and edges may have some wear. Mild to Moderate creasing / bending to covers and pages.

hardcover. Condition: Very Good. Remainder with a "damaged" stamp to copyright page - upper board corners slightly bumped - minimal surface wear - very good condition.

hardcover. Condition: Like New. A firm and square hardback with sharp corners and strong joints just showing a few very minor rubs. Hence a non-text page has a small 'damaged' stamp. Despite such this book is actually in nearly new condition and appears unread. Thus the contents are crisp, fresh and tight. Also, no pen-marks and not from a library so no such stamps or labels. Now offered for sale at a very sensible price.…

Condition: New.

Condition: New.

Condition: As New. Unread book in perfect condition.

Condition: New.

Condition: New.

Condition: New. In English.

Condition: As New. Unread book in perfect condition.

Condition: New.

Condition: New. New edition NO-PA16APR2015-KAP.

Hardcover. Condition: Brand New. 1st edition. 554 pages. 10.00x7.25x1.25 inches. In Stock.

Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Alzheimer's Disease (AD) is a growing global public health challenge. The development of new therapies is urgently needed, and a complex ecosystem of organizations has grown to facilitate AD drug discovery and development. Masterfully collating information on the drug development ecosystem, this book emphasizes the contributions of each aspect in the pipeline with a uniform approach to chapters, enabling readers to access relevant information quickly. Topics covered include the use of non-clinical laboratory studies, biomarker development, artificial intelligence, design and management of clinical trials, and funding and financing models. Also discussed is the critical role of advocacy fundraising for drug development. With the approval of aducanumab, the function of the ecosystem has become apparent. This is a definitive overview of how the ecosystem works in transferring an AD drug from its discovery in the laboratory through clinical trial testing to regulatory review and eventual marketing. …

Hardcover. Condition: new. Hardcover. Alzheimer's Disease (AD) is a growing global public health challenge. The development of new therapies is urgently needed, and a complex ecosystem of organizations has grown to facilitate AD drug discovery and development. Masterfully collating information on the drug development ecosystem, this book emphasizes the contributions of each aspect in the pipeline with a uniform approach to chapters, enabling readers to access relevant information quickly. Topics covered include the use of non-clinical laboratory studies, biomarker development, artificial intelligence, design and management of clinical trials, and funding and financing models. Also discussed is the critical role of advocacy fundraising for drug development. With the approval of aducanumab, the function of the ecosystem has become apparent. This is a definitive overview of how the ecosystem works in transferring an AD drug from its discovery in the laboratory through clinical trial testing to regulatory review and eventual marketing. Provides a definitive overview of the complex ecosystem facilitating Alzheimer's Disease drug research and development. Demonstrates a drug's journey from in the lab, clinical trial testing, regulatory review, and marketing by pharmaceutical companies. Details the use of artificial intelligence, clinical trial management, and financing models. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

Condition: New. Print on Demand.

Condition: New. PRINT ON DEMAND.

Gebunden. Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Provides a definitive overview of the complex ecosystem facilitating Alzheimer s Disease drug research and development. Demonstrates a drug s journey from in the lab, clinical trial testing, regulatory review, and marketing by pharmaceutical companies. Deta.…

Buch. Condition: Neu. Alzheimer's Disease Drug Development | Jeffrey Cummings (u. a.) | Buch | Gebunden | Englisch | 2022 | Cambridge University Press | EAN 9781108838665 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.…